维他可可
COCO
58.69
+1.02
+1.77%
维他可可
US · COCO
#2437 按市值排名
上市于 2021
58.69
+1.02
+1.77%
实时 - 追踪5344个代码 - 心跳于129秒前
· 2026-10-16 19:30
✦ 量化股权信号 计算方式说明
减持
- 最近一期（2026/Q3）披露持股的机构数量增加了4家。
- 机构持股总比例下降了2.7个百分点。
机构持股
- 机构持股比例
- 87.73% -2.66pp
- 机构数量
- 417 +4
- 数据截至
- 2026/Q3 较上一报告期
持股变动 vs 资金流向
方向分歧机构在上一报告期减持了股份，同时该股在最近20个交易日的主力资金呈净流入——两者方向出现分歧。
机构持股变动数据按季度发布且存在滞后；资金流向数据为每日更新。请将其作为方向性的交叉验证参考，而非精确的择时信号。
持股人类型
Mutual Fund70.21%
Hedge Fund7.83%
Individual/Insider7.71%
Private Company5.29%
Public Company2.40%
Government Pension Fund1.14%
Insurance Company0.62%
Family Office/Trust0.17%
Other4.60%
主要股东 截至 2026-06-30
BlackRock
11.85% · 7.01M 股
FMR
5.43% · 3.21M 股
Vanguard Capital Management, LLC
4.09% · 2.42M 股
Wasatch Advisors LP
3.81% · 2.26M 股
Michael Kirban
3.50% · 2.07M 股
State Street Global Advisors
3.12% · 1.85M 股
Wellington Management Group
3.12% · 1.84M 股
Driehaus Capital Management LLC
2.54% · 1.50M 股
Geode Capital Management, LLC
2.33% · 1.38M 股
Vanguard Portfolio Management, LLC
2.10% · 1.24M 股
条形长度是相对于此处列出的最大股东而言，并非相对于公司100%股权。
内部人持股
共追踪50份申报 · 7次买入 · 43次卖出
| 姓名 | 职务 | 持股比例 |
|---|---|---|
| Michael Kirban | Co-Founder, Executive Chairman & President | 3.50% |
| Martin Roper | Chief Executive Officer | 1.67% |
| Ira Liran | Co-Founder | 1.20% |
| Kenneth Sadowsky | Independent Director | 0.98% |
| Jane Prior | Chief Marketing Officer | 0.14% |
| Charles Van Es | Chief Sales Officer | 0.08% |
| Jane Morreau | Independent Director | 0.03% |
| John Leahy | Independent Non-Executive Director | 0.03% |
| Aishetu Dozie | Independent Director | 0.03% |
| Jonathan Burth | Chief Operating Officer | 0.02% |
内部人交易 最近的 Form 4 申报记录
| 日期 | 姓名 | 职务 | 类型 | 股数 | 价格 |
|---|---|---|---|---|---|
| 2026-08-14 | Jonathan Burth | Chief Operating Officer | Sale to Issuer | -10,801 | $65.21 |
| 2026-08-14 | Jane Prior | Chief Marketing Officer | Sale to Issuer | -10,801 | $65.21 |
| 2026-08-14 | Charles Van Es | Chief Sales Officer | Sale to Issuer | -10,801 | $65.21 |
| 2026-06-16 | Kenneth Sadowsky | Independent Director | Automatic Disposition | -3,900 | $82.92 |
| 2026-06-11 | Ira Liran | Co-Founder | Automatic Disposition | -148,074 | $80.29–80.32 |
| 2026-06-10 | Ira Liran | Co-Founder | Automatic Disposition | -191,926 | $79.14 |
| 2026-06-10 | Jonathan Burth | Chief Operating Officer | Derivative Exercise and Sale | -30,000 | $10.18–80.00 |
| 2026-06-02 | Shelley Broader | Director | Other Acquisition | +1,530 | $75.18 |
| 2026-06-02 | Jane Morreau | Independent Director | Other Acquisition | +1,530 | $75.18 |
| 2026-06-02 | Ira Liran | Co-Founder | Other Acquisition | +1,530 | $75.18 |
| 2026-06-02 | Kenneth Sadowsky | Independent Director | Other Acquisition | +1,530 | $75.18 |
| 2026-06-02 | Eric Melloul | Independent Director | Other Acquisition | +1,530 | $75.18 |
| 2026-06-02 | John Zupo | Director | Other Acquisition | +1,530 | $75.18 |
| 2026-06-02 | Aishetu Dozie | Independent Director | Other Acquisition | +1,530 | $75.18 |
| 2026-05-31 | Charles Van Es | Chief Sales Officer | Automatic Disposition | -8,045 | $75.05 |
| 2026-05-19 | Kenneth Sadowsky | Independent Director | Automatic Disposition | -3,900 | $77.48 |
| 2026-05-11 | Jonathan Burth | Chief Operating Officer | Derivative Exercise and Sale | -30,000 | $10.18–75.00 |
| 2026-05-07 | Jonathan Burth | Chief Operating Officer | Derivative Exercise and Sale | -20,000 | $10.18–70.00 |
| 2026-05-07 | Charles Van Es | Chief Sales Officer | Automatic Disposition | -8,561 | $70.00 |
| 2026-04-30 | Charles Van Es | Chief Sales Officer | Automatic Disposition | -2,000 | $66.87 |
Form 4 申报记录，每家公司显示最新的一批。"Other Derivative Acquisition"（其他衍生品获取）类目多为限制性股票/期权归属，并非公开市场买入——具体类型见"类型"列。
报价时间 2026-10-16 19:30:05 · 仅供参考，不构成投资建议，也未考虑您的具体情况。
维他可可 讨论区 0 条评论